Near­ly out of cash, a for­mer Sarep­ta part­ner asks French courts to over­see re­struc­tur­ing

Lyso­gene is tee­ter­ing on the edge.

The Paris biotech re­quest­ed the coun­try’s gov­ern­ment open what’s known as a “safe­guard pro­ceed­ing” on Tues­day, a le­gal ma­neu­ver …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER